Pharma Journalist 8791 posts 0 comments

Exscientia, the clinical stage, Artificial Intelligence (AI)-driven pharmatech company, announced that it has entered into a collaboration agreement with Bristol-Myers Squibb Company.…
Read More...

Gamma Biosciences, a global life sciences company serving the advanced therapy market, announced that it has agreed to make a controlling investment in Mirus Bio, an innovator and…
Read More...

Bristol-Myers Squibb Company and Agenus Inc. announced that they have entered into a definitive agreement under which Bristol Myers Squibb will be granted a global exclusive license to…
Read More...

Sandoz, a Novartis division, announces plans to further strengthen its European antibiotics manufacturing network by further expanding production capabilities in Kundl, Austria and in…
Read More...

SMi Group reports: The Aseptic Processing Conference will be held on 20th and 21st September 2021 in London, UK. The conference will explore effective strategies and new regulations for…
Read More...

CytoDyn Inc. a late-stage biotechnology company developing Vyrologix™ (leronlimab-PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announced it…
Read More...

Prestige BioPharma Limited (PBP) and Busan City Government announced that the two organisations have entered into a memorandum of understanding (MOU) for the establishment of Research…
Read More...

BioMed X announced the extension of its ongoing collaboration with Merck. Under the new agreement, Merck will start up to six additional research projects at the BioMed X Institute,…
Read More...

InnoCare a leading biopharmaceutical company focusing on cancer and autoimmune diseases, announced that China National Medical Products Administration has approved the Phase I clinical…
Read More...

SMi Reports: Registration is open for SMi Group’s 2nd annual Wearable Injectors and Connected Devices Conference taking place 18th -19th October in London. This Conference will explore…
Read More...